179 related articles for article (PubMed ID: 35345275)
1. Restrictive cardiomyopathy: from genetics and clinical overview to animal modeling.
Chintanaphol M; Orgil BO; Alberson NR; Towbin JA; Purevjav E
Rev Cardiovasc Med; 2022 Mar; 23(3):108. PubMed ID: 35345275
[TBL] [Abstract][Full Text] [Related]
2. Overview of Restrictive Cardiomyopathies.
Gowda SN; Ali HJ; Hussain I
Methodist Debakey Cardiovasc J; 2022; 18(2):4-16. PubMed ID: 35414858
[TBL] [Abstract][Full Text] [Related]
3. Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
Muchtar E; Blauwet LA; Gertz MA
Circ Res; 2017 Sep; 121(7):819-837. PubMed ID: 28912185
[TBL] [Abstract][Full Text] [Related]
4. Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy.
Caleshu C; Sakhuja R; Nussbaum RL; Schiller NB; Ursell PC; Eng C; De Marco T; McGlothlin D; Burchard EG; Rame JE
Am J Med Genet A; 2011 Sep; 155A(9):2229-35. PubMed ID: 21823217
[TBL] [Abstract][Full Text] [Related]
5. Titin mutation in familial restrictive cardiomyopathy.
Peled Y; Gramlich M; Yoskovitz G; Feinberg MS; Afek A; Polak-Charcon S; Pras E; Sela BA; Konen E; Weissbrod O; Geiger D; Gordon PM; Thierfelder L; Freimark D; Gerull B; Arad M
Int J Cardiol; 2014 Jan; 171(1):24-30. PubMed ID: 24315344
[TBL] [Abstract][Full Text] [Related]
6. Novel combination of
Kumar V; Kumar P; Chauhan L; Dwivedi A; Ramamurthy HR
J Genet; 2022; 101():. PubMed ID: 36560844
[TBL] [Abstract][Full Text] [Related]
7. Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.
Li Y; Charles PY; Nan C; Pinto JR; Wang Y; Liang J; Wu G; Tian J; Feng HZ; Potter JD; Jin JP; Huang X
J Mol Cell Cardiol; 2010 Sep; 49(3):402-11. PubMed ID: 20580639
[TBL] [Abstract][Full Text] [Related]
8. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
[TBL] [Abstract][Full Text] [Related]
9. Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy.
Brodehl A; Ferrier RA; Hamilton SJ; Greenway SC; Brundler MA; Yu W; Gibson WT; McKinnon ML; McGillivray B; Alvarez N; Giuffre M; Schwartzentruber J; ; Gerull B
Hum Mutat; 2016 Mar; 37(3):269-79. PubMed ID: 26666891
[TBL] [Abstract][Full Text] [Related]
10. Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy.
Huby AC; Mendsaikhan U; Takagi K; Martherus R; Wansapura J; Gong N; Osinska H; James JF; Kramer K; Saito K; Robbins J; Khuchua Z; Towbin JA; Purevjav E
J Am Coll Cardiol; 2014 Dec; 64(25):2765-76. PubMed ID: 25541130
[TBL] [Abstract][Full Text] [Related]
11. Novel pathogenic variants in filamin C identified in pediatric restrictive cardiomyopathy.
Schubert J; Tariq M; Geddes G; Kindel S; Miller EM; Ware SM
Hum Mutat; 2018 Dec; 39(12):2083-2096. PubMed ID: 30260051
[TBL] [Abstract][Full Text] [Related]
12. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium.
Bermúdez-Jiménez FJ; Carriel V; Santos-Mateo JJ; Fernández A; García-Hernández S; Ramos KA; Piqueras-Flores J; Cabrera-Romero E; Barriales-Villa R; de la Higuera Romero L; Alcalá López JE; Gimeno Blanes JR; Sánchez-Porras D; Campos F; Alaminos M; Oyonarte-Ramírez JM; Álvarez M; Tercedor L; Brodehl A; Jiménez-Jáimez J
Rev Esp Cardiol (Engl Ed); 2023 May; 76(5):301-311. PubMed ID: 35952944
[TBL] [Abstract][Full Text] [Related]
13. Novel Mutation in
Tucker NR; McLellan MA; Hu D; Ye J; Parsons VA; Mills RW; Clauss S; Dolmatova E; Shea MA; Milan DJ; Scott NS; Lindsay M; Lubitz SA; Domian IJ; Stone JR; Lin H; Ellinor PT
Circ Cardiovasc Genet; 2017 Dec; 10(6):. PubMed ID: 29212899
[TBL] [Abstract][Full Text] [Related]
14. Rare clinical phenotype of filaminopathy presenting as restrictive cardiomyopathy and myopathy in childhood.
Muravyev A; Vershinina T; Tesner P; Sjoberg G; Fomicheva Y; Čajbiková NN; Kozyreva A; Zhuk S; Mamaeva E; Tarnovskaya S; Jornholt J; Sokolnikova P; Pervunina T; Vasichkina E; Sejersen T; Kostareva A
Orphanet J Rare Dis; 2022 Sep; 17(1):358. PubMed ID: 36104822
[TBL] [Abstract][Full Text] [Related]
15. Restrictive cardiomyopathy: definition and diagnosis.
Rapezzi C; Aimo A; Barison A; Emdin M; Porcari A; Linhart A; Keren A; Merlo M; Sinagra G
Eur Heart J; 2022 Dec; 43(45):4679-4693. PubMed ID: 36269634
[TBL] [Abstract][Full Text] [Related]
16. [Non-compaction and restrictive cardiomyopathy in pediatrics: Two types of myocardial diseases that are important to recognize].
Álvarez Zenteno P; Meza Peñafiel L; Aroca Del Río P
Andes Pediatr; 2021 Oct; 92(5):667-676. PubMed ID: 35319572
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations.
Li Y; Zhang L; Jean-Charles PY; Nan C; Chen G; Tian J; Jin JP; Gelb IJ; Huang X
J Mol Cell Cardiol; 2013 Sep; 62():227-36. PubMed ID: 23810866
[TBL] [Abstract][Full Text] [Related]
18. Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.
Hasegawa M; Miki K; Kawamura T; Takei Sasozaki I; Higashiyama Y; Tsuchida M; Kashino K; Taira M; Ito E; Takeda M; Ishida H; Higo S; Sakata Y; Miyagawa S
Dev Growth Differ; 2024 Feb; 66(2):119-132. PubMed ID: 38193576
[TBL] [Abstract][Full Text] [Related]
19. Applicability of published guidelines for assessment of left ventricular diastolic function in adults to children with restrictive cardiomyopathy: an observational study.
Sasaki N; Garcia M; Ko HH; Sharma S; Parness IA; Srivastava S
Pediatr Cardiol; 2015 Feb; 36(2):386-92. PubMed ID: 25193183
[TBL] [Abstract][Full Text] [Related]
20. A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin.
Pinto JR; Parvatiyar MS; Jones MA; Liang J; Potter JD
J Biol Chem; 2008 Jan; 283(4):2156-66. PubMed ID: 18032382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
